3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid
C9H16FN2O3P — CID 145423553
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid
3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid (PubChem CID 145423553) has the molecular formula C9H16FN2O3P and a molecular weight of 250.21 g/mol. Its IUPAC name is 3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid.
Molecular Properties
| Compound Name | 3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid |
|---|---|
| PubChem CID | 145423553 |
| Molecular Formula | C9H16FN2O3P |
| Molecular Weight | 250.21 g/mol |
| Exact Mass | 250.09 |
| IUPAC Name | 3-[1-[[(1E)-buta-1,3-dienyl]amino]ethenylamino]propyl-fluorooxyphosphinic acid |
| SMILES | C=C/C=C/NC(=C)NCCCP(=O)(O)OF |
| InChI | InChI=1S/C9H16FN2O3P/c1-3-4-6-11-9(2)12-7-5-8-16(13,14)15-10/h3-4,6,11-12H,1-2,5,7-8H2,(H,13,14)/b6-4+ |
| InChIKey | LAMWCZXQXLFIIS-GQCTYLIASA-N |
| XLogP | 1.81 |
| TPSA | 70.59 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 16 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 250.21 |
| LogP ≤ 5 | 1.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145423553 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.